Corbus Pharma Reports Director/Officer Changes & Financials
Ticker: CRBP · Form: 8-K · Filed: Mar 18, 2025 · CIK: 1595097
Sentiment: neutral
Topics: management-change, financials, corporate-governance
TL;DR
Corbus Pharma's 8-K: Board/exec changes, financials filed. Watch for strategy shifts.
AI Summary
Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on March 18, 2025, reporting on events as of March 13, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
Changes in a company's board and executive team, along with financial disclosures, can signal shifts in strategy or operational performance that may impact investors.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if numerous or unexpected, can indicate internal instability or strategic realignments that carry inherent risks.
Key Numbers
- 001-37348 — SEC File Number (Identifies the company's filing history with the SEC.)
- 46-4348039 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Corbus Pharmaceuticals Holdings, Inc. (company) — Registrant
- March 13, 2025 (date) — Earliest event reported
- March 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Norwood, Massachusetts (location) — Principal executive offices
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates events related to the departure of directors or certain officers, the election of directors, and the appointment of certain officers.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated March 13, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on March 18, 2025.
What are the principal executive offices of Corbus Pharmaceuticals Holdings, Inc.?
The principal executive offices are located at 500 River Ridge Drive, Norwood, Massachusetts 02062.
What other information is included in this filing besides personnel changes?
The filing also includes financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding Corbus Pharmaceuticals Holdings, Inc. (CRBP).